Back to Results
First PageMeta Content
Biology / Progeria / Health / Medicine / Farnesyltransferase inhibitor / Prenylation / Progerin / Farnesyltransferase / Life extension / Aging / Genodermatoses / Gerontology


Contact: Ashley Moore[removed]removed] STUDY FINDS TRIAL MEDICATIONS INCREASE LIFESPAN FOR CHILDREN WITH PROGERIA
Add to Reading List

Document Date: 2014-05-06 18:47:49

Open Document

File Size: 102,09 KB

Share Result on Facebook

City

BOSTON / /

Company

Merck & Co. / Brigham / Dana / /

/

Facility

Brown University / Women’s Hospital / Blood Institute / Boston University / Hasbro Children’s Hospital / Boston Children’s Hospital / Hospital Cancer Center / /

MedicalCondition

rapid aging disease / age-related disorders / cancer / Progeria / disease / atherosclerosis / atherogenesis / same heart disease / initial Progeria / telomere dysfunction / stroke / heart disease / cardiovascular disease / fatal disease / untreated Progeria / heart attacks / rare / fatal genetic disease / Hutchinson-Gilford Progeria Syndrome / /

Organization

Harvard Medical School / Boston Children’s Hospital / Hasbro Children’s Hospital / Hospital Cancer Center / Brown University / Alpert Medical School / Women’s Hospital / Progeria Research Foundation / Boston University / National Heart / Lung and Blood Institute / /

Person

Fuki M. Hisama / Audrey Gordon / Junko Oshima / George M. Martin / Leslie Gordon / Elizabeth G. Nabel / Mark Kieran / Ashley Moore / /

/

Position

principal investigator / Executive Director / President / staff scientist / Director / lead and corresponding author / Medical Director / director of pediatric medical neuro-oncology / Associate Professor / /

URL

www.progeriaresearch.org / /

SocialTag